Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles

BACKGROUND: It is difficult to discriminate healthy subjects and patients with Parkinson disease (PD) or Parkinson disease dementia (PDD) by assaying plasma α-synuclein because the concentrations of circulating α-synuclein in the blood are almost the same as the low-detection limit using current imm...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Nanobiotechnology
Main Authors: Yang, Shieh-Yueh, Chiu, Ming-Jang, Lin, Chin-Hsien, Horng, Herng-Er, Yang, Che-Chuan, Chieh, Jen-Jie, Chen, Hsin-Hsien, Liu, Bing-Hsien
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4898388/
https://ncbi.nlm.nih.gov/pubmed/27278241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-016-0198-5
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki